These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 897649)

  • 1. [Effect of aluminium-hydroxide-containing antacids on the intestinal absorption of iron in patients on long-term dialysis].
    Blumberg A
    Schweiz Med Wochenschr; 1977 Jul; 107(30):1064-6. PubMed ID: 897649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z; Jobst K; Nagy J
    Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Administration of colloidal aluminium hydroxide to patients under chronic hemodialysis].
    Vokrouhlická O; Erben J; Zahradník J; Dvoráková-Bastecká D
    Cas Lek Cesk; 1977 May; 116(19):594-7. PubMed ID: 880597
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of deferoxamine on erythropoiesis in patients hemodialyzed for chronic renal insufficiency treated with erythropoietin].
    Kalinowski M; Popławski A; Kaliszewski Z; Juzwiuk J
    Pol Merkur Lekarski; 1996 Oct; 1(4):232-4. PubMed ID: 9156931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral iron absorption in hemodialysis patients treated with erythropoietin.
    Donnelly SM; Posen GA; Ali MA
    Clin Invest Med; 1991 Aug; 14(4):271-6. PubMed ID: 1782724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL; Leu ML
    Nephrol Dial Transplant; 1996 Sep; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of the possible influence of the absorption of vinpocetine with concomitant application of magnesium-aluminium-hydroxide gel.
    Lohmann A; Grobara P; Dingler E
    Arzneimittelforschung; 1991 Nov; 41(11):1164-7. PubMed ID: 1810262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aluminum hydroxide on iron absorption.
    Rastogi SP; Padilla F; Boyd CM
    J Ark Med Soc; 1976 Aug; 73(3):133-4. PubMed ID: 134015
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia.
    Milman N
    Clin Nephrol; 1982 Feb; 17(2):77-81. PubMed ID: 6802544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aluminum and magnesium burden of dialysis patients using antacids. A comparative study].
    Eichhorn M
    Fortschr Med; 1989 Aug; 107(23):502-6. PubMed ID: 2670719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aluminum absorption in the presence of normal kidney function: the effect of the pH].
    Olaizola Ottonello I; Serrano Arias M; Vizoso Piñeiro F; Rodrigo Saez L; García Morán M; Cannata Andía JB
    Rev Clin Esp; 1991 May; 188(9):442-5. PubMed ID: 1896590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minor impairment of oral iron absorption in non-diabetic new dialysis patients.
    Tovbin D; Schnaider A; Vorobiov M; Rogachev B; Basok A; Shull P; Novack V; Friger M; Avramov D; Zlotnik M
    J Nephrol; 2005; 18(2):174-80. PubMed ID: 15931645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antacids on the absorption of simultaneously ingested iron.
    O'Neil-Cutting MA; Crosby WH
    JAMA; 1986 Mar; 255(11):1468-70. PubMed ID: 3005669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction of haemodialysis-associated anaemia by deferoxamine. Effects on serum aluminum and iron overload.
    von Bonsdorff M; Sipilä R; Pitkänen E
    Scand J Urol Nephrol Suppl; 1990; 131():49-54. PubMed ID: 2075470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aluminium load in patients with analgesic nephropathy.
    Schwarz A; Kraft D; Keller F; Gawlik D; Offermann G
    Miner Electrolyte Metab; 1987; 13(3):141-6. PubMed ID: 3627045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous hyperparathyroidism not associated with increased aluminum absorption.
    Mocan MZ; Mocan H; Fell GS; Junor BJ; Boyce BF
    Isr J Med Sci; 1992 Jan; 28(1):24-6. PubMed ID: 1733894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of aluminium- and magnesium hydroxide (Alucol) on cortisone absorption].
    Galeazzi RL; Gerber N; Iff HW
    Schweiz Med Wochenschr; 1973 Jul; 103(29):1021-3. PubMed ID: 4719902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.